Obesity trials in Türkiye
17 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Adana, Ankara, Antalya, Istanbul, Izmir, Sariçam
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058EU 2025-523106-32-00Registry updated 2026-11-09
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Ankara, Antalya, Center, Istanbul
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509EU 2025-523295-23-00Registry updated 2026-11-09
No phaseRecruitingResearch participation
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
- Where
- Denizli
- Age
- 18 years to 65 years
- People
- 30
- Run by
- Pamukkale University
See details and how to joinNCT07924436Registry updated 2026-11-09
No phaseRecruitingResearch participation
Ocular Changes in Patients Using Tirzepatide or Semaglutide
- Where
- Istanbul
- Age
- 18 years and over
- People
- 40
- Run by
- Istanbul University
See details and how to joinNCT07924618Registry updated 2026-11-09
No phaseRecruitingResearch participation
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity
- Where
- Van
- Age
- 18 years and over
- People
- 200
- Run by
- Yuzuncu Yil University
See details and how to joinNCT07901777Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Ankara, Antalya, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin
- Age
- 18 years to 70 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086EU 2024-520209-38-00Registry updated 2026-11-04
Phase 3RecruitingTrial-stage medicine
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Ankara, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin, Muratpaşa
- Age
- 18 years to 70 years
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099EU 2024-520210-21-00Registry updated 2026-11-04
Phase 3Not yet recruitingTrial-stage medicine
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Adana, Ankara, Antalya, Diyarbakır, Eskişehir, Istanbul, Kayseri, Kocaeli, Yüreğir
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633EU 2026-525919-14-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Adana, Afyonkarahisar, Ankara, Çorum, Eskişehir, Istanbul, Izmir, Kayseri, Kocaeli, Konya
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459Registry updated 2026-10-29
Phase 3RecruitingTrial-stage medicine
A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
- Where
- Ankara, Kayseri
- Age
- 2 years and over
- People
- 4 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07220772EU 2024-518674-14-00Registry updated 2026-10-22
Phase 3RecruitingTrial-stage medicine
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Adana, Adapazarı, Ankara, Antalya, Istanbul
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803Registry updated 2026-10-13
Phase 3RecruitingTrial-stage medicine
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Alanya/ Antalya, Maltepe/İstanbull, Merkez/Battalgazi/Malatya, Merkez/Çorum, Yenimahalle / Ankara, Yıldırım/Bursa, Yuregir/Adana, Zeytinburnu/İstanbul
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571109EU 2024-520443-16-00Registry updated 2026-10-07
Phase 3RecruitingTrial-stage medicine
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Alanya/ Antalya, Maltepe/İstanbull, Merkez/Battalgazi/Malatya, Merkez/Çorum, Yenimahalle / Ankara, Yıldırım/Bursa, Yuregir/Adana, Zeytinburnu/İstanbul
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571005EU 2024-520442-36-00Registry updated 2026-09-11
Phase 3RecruitingTrial-stage medicine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Adana, Adapazarı/Sakarya, Afyonkarahisar, Altınordu/Ordu, Ankara, Antalya, Bayraklı/İzmir, Bursa, Çanakkale/Türkiye, Canik/Samsun, Eskişehir, Istanbul, Izmir, Kayseri, Keçiören/Ankara, Kocaeli, Kütahya, Malatya, Merkez/elaziğ, Mersin, Muratpasa/ Antalya, Yakutiye / Erzurum, Yenimahalle/Ankara, Yuregir/Adana
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001EU 2025-523717-29-00Registry updated 2026-08-18
Phase 3RecruitingTrial-stage medicine
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Where
- Bahçelievler/İstanbul, Çankaya/Ankara, Edirne, Fatih/İstanbul, Yıldırım/Bursa, Yuregir/Adana
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07509307EU 2024-520445-23-00Registry updated 2026-08-17
No phaseRecruitingResearch participation
UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers
- Where
- Ankara
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT07652151Registry updated 2026-06-23
Phase 2RecruitingTrial-stage medicine
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli
- Age
- 18 years and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698EU 2024-510846-15-00Registry updated 2026-03-11
All Obesity trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.